Suppr超能文献

一种基于茄呢醇衍生支架的生物活性肽多聚化方法。

A solanesol-derived scaffold for multimerization of bioactive peptides.

机构信息

Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona 85721-0041, USA.

出版信息

J Org Chem. 2010 Sep 3;75(17):5895-903. doi: 10.1021/jo101043m.

Abstract

A flexible molecular scaffold bearing varying numbers of terminal alkyne groups was synthesized in five steps from solanesol. R(CO)-MSH(4)-NH(2) ligands, which have a relatively low affinity for binding at the human melanocortin 4 receptor (hMC4R), were prepared by solid phase synthesis and were N-terminally acylated with 6-azidohexanoic acid. Multiple copies of the azide N(3)(CH(2))(5)(CO)-MSH(4)-NH(2) were attached to the alkyne-bearing, solanesol-derived molecular scaffold via the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction. Control studies showed that the binding affinity of the triazole-containing ligand, CH(3)(CH(2))(3)(C(2)N(3))(CH(2))(5)(CO)-MSH(4)-NH(2), was not significantly diminished relative to the corresponding parental ligand, CH(3)(CO)-MSH(4)-NH(2). In a competitive binding assay with a Eu-labeled probe based on the superpotent ligand NDP-alpha-MSH, the monovalent and multivalent constructs appear to bind to hMC4R as monovalent species. In a similar assay with a Eu-labeled probe based on MSH(4), modest increases in binding potency with increased MSH(4) content per scaffold were observed.

摘要

一种带有不同数量末端炔基的柔性分子支架,通过五步从茄呢醇合成。R(CO)-MSH(4)-NH(2)配体对人黑素皮质素 4 受体(hMC4R)的结合亲和力相对较低,通过固相合成制备,并与 6-叠氮己酸进行 N 端酰化。多个叠氮 N(3)(CH(2))(5)(CO)-MSH(4)-NH(2)通过铜(I)催化的叠氮-炔环加成(CuAAC)反应连接到带有炔基的茄呢醇衍生的分子支架上。对照研究表明,含有三唑的配体 CH(3)(CH(2))(3)(C(2)N(3))(CH(2))(5)(CO)-MSH(4)-NH(2)的结合亲和力相对于相应的母体配体 CH(3)(CO)-MSH(4)-NH(2)没有明显降低。在基于超效配体 NDP-alpha-MSH 的 Eu 标记探针的竞争性结合测定中,单价和多价构建体似乎作为单价物质结合 hMC4R。在基于 MSH(4)的 Eu 标记探针的类似测定中,观察到随着支架上 MSH(4)含量的增加,结合效力适度增加。

相似文献

1
A solanesol-derived scaffold for multimerization of bioactive peptides.
J Org Chem. 2010 Sep 3;75(17):5895-903. doi: 10.1021/jo101043m.
2
Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.
Bioorg Med Chem. 2013 Sep 1;21(17):5029-38. doi: 10.1016/j.bmc.2013.06.052. Epub 2013 Jul 2.
3
Squalene-derived flexible linkers for bioactive peptides.
Bioorg Med Chem Lett. 2007 Jun 15;17(12):3310-3. doi: 10.1016/j.bmcl.2007.04.001. Epub 2007 Apr 6.
4
A sucrose-derived scaffold for multimerization of bioactive peptides.
Bioorg Med Chem. 2011 Nov 1;19(21):6474-82. doi: 10.1016/j.bmc.2011.08.053. Epub 2011 Aug 27.
6
Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.
Bioorg Med Chem Lett. 2010 Apr 15;20(8):2489-92. doi: 10.1016/j.bmcl.2010.03.007. Epub 2010 Mar 4.
7
The "click" reaction involving metal azides, metal alkynes, or both: an exploration into multimetal structures.
Chemistry. 2013 Mar 11;19(11):3534-41. doi: 10.1002/chem.201204596. Epub 2013 Feb 18.
8
Quick and highly efficient copper-catalyzed cycloaddition of organic azides with terminal alkynes.
Org Biomol Chem. 2012 Jan 14;10(2):229-31. doi: 10.1039/c1ob06190a. Epub 2011 Oct 24.
9
Chelation-assisted, copper(II)-acetate-accelerated azide-alkyne cycloaddition.
J Org Chem. 2010 Oct 1;75(19):6540-8. doi: 10.1021/jo101305m.
10
Copper catalysed azide-alkyne cycloaddition (CuAAC) in liquid ammonia.
Org Biomol Chem. 2012 Oct 21;10(39):7965-9. doi: 10.1039/c2ob26213d.

引用本文的文献

2
Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.
Biochim Biophys Acta Mol Basis Dis. 2017 Oct;1863(10 Pt A):2414-2435. doi: 10.1016/j.bbadis.2017.03.020. Epub 2017 Mar 29.
3
Synthesis and bioactivity of MSH4 oligomers prepared by an A + B strategy.
Tetrahedron Lett. 2015 Jun 3;56(23):3060-3065. doi: 10.1016/j.tetlet.2014.12.022.
4
Trigonal scaffolds for multivalent targeting of melanocortin receptors.
Org Biomol Chem. 2015 Feb 14;13(6):1778-91. doi: 10.1039/c4ob02094d.
5
Synthesis and characterization of time-resolved fluorescence probes for evaluation of competitive binding to melanocortin receptors.
Bioorg Med Chem. 2013 Sep 1;21(17):5029-38. doi: 10.1016/j.bmc.2013.06.052. Epub 2013 Jul 2.
6
Multivalency amplifies the selection and affinity of bradykinin-derived peptides for lipid nanovesicles.
Mol Biosyst. 2013 Aug;9(8):2005-9. doi: 10.1039/c3mb70109c. Epub 2013 May 28.
7
Design, Synthesis, and Testing of a Molecular Truck for Colonic Delivery of 5-Aminosalicylic Acid.
ACS Med Chem Lett. 2012 Sep 13;3(9):710-714. doi: 10.1021/ml300086c. Epub 2012 Aug 1.
8
A sucrose-derived scaffold for multimerization of bioactive peptides.
Bioorg Med Chem. 2011 Nov 1;19(21):6474-82. doi: 10.1016/j.bmc.2011.08.053. Epub 2011 Aug 27.

本文引用的文献

1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
2
Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.
Bioorg Med Chem Lett. 2010 Apr 15;20(8):2489-92. doi: 10.1016/j.bmcl.2010.03.007. Epub 2010 Mar 4.
4
Effects of linker length and flexibility on multivalent targeting.
Biomacromolecules. 2008 Nov;9(11):3057-64. doi: 10.1021/bm800529b. Epub 2008 Oct 2.
5
Statistical thermodynamics of the stability of multivalent ligand-receptor complexes.
Phys Rev Lett. 2008 May 2;100(17):178101. doi: 10.1103/PhysRevLett.100.178101. Epub 2008 Apr 28.
6
Modification of embolic-PVA particles with MR contrast agents.
Magn Reson Med. 2008 Apr;59(4):898-902. doi: 10.1002/mrm.21518.
9
Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions.
Chem Soc Rev. 2007 Oct;36(10):1674-89. doi: 10.1039/b701444a. Epub 2007 Jun 12.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验